17V Stock Overview
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Venture Life Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.47 |
| 52 Week High | UK£0.48 |
| 52 Week Low | UK£0.31 |
| Beta | 0.26 |
| 1 Month Change | 14.01% |
| 3 Month Change | 20.41% |
| 1 Year Change | 0.85% |
| 3 Year Change | -51.59% |
| 5 Year Change | n/a |
| Change since IPO | -48.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| 17V | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 9.3% | 4.4% | 1.7% |
| 1Y | 0.9% | -2.0% | 2.3% |
Price Volatility
| 17V volatility | |
|---|---|
| 17V Average Weekly Movement | 6.8% |
| Personal Products Industry Average Movement | 4.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Volatility Over Time: 17V's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 153 | Jerry Randall | www.venture-life.com |
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products; oncology products, including Gelclair, Pomi-T, and Xonrid that provides symptomatic relief for some of the side effects associated with cancer and its treatment; Earol and EarolSwim for the removal of ear wax, ensure ear hygiene and soothe, and prevent itchy and irritated ears; Sterinase supports nasal irrigation and hygiene; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness.
Venture Life Group plc Fundamentals Summary
| 17V fundamental statistics | |
|---|---|
| Market cap | €62.35m |
| Earnings (TTM) | -€881.89k |
| Revenue (TTM) | €56.66m |
1.1x
P/S Ratio-70.7x
P/E RatioIs 17V overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 17V income statement (TTM) | |
|---|---|
| Revenue | UK£48.57m |
| Cost of Revenue | UK£29.85m |
| Gross Profit | UK£18.73m |
| Other Expenses | UK£19.49m |
| Earnings | -UK£756.00k |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.006 |
| Gross Margin | 38.56% |
| Net Profit Margin | -1.56% |
| Debt/Equity Ratio | 25.7% |
How did 17V perform over the long term?
See historical performance and comparison